About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Antiviral Activity of New Coronavirus Inhibitor

by Himabindu Venkatakrishnan on May 30, 2014 at 12:27 PM
Font : A-A+

 Antiviral Activity of New Coronavirus Inhibitor

Coronaviruses have recently been confirmed to represent a serious threat, as they have been on the watch list for emerging pathogens since the SARS epidemic 2003. No specific drugs exist against coronaviruses so far, but an article published on May 29th in PLOS Pathogens introduces a new inhibitor of coronaviruses and implicates a specific process in the life cycle of these viruses that it blocks.

Searching for inhibitors of coronaviruses, an international team of scientists led by Edward Trybala, from the University of Gothenburg, Sweden, and Volker Thiel, from the University of Berne, Switzerland, identified a compound called K22. They initially discovered that K22 had antiviral activity against a relatively harmless coronavirus that causes mild cold-like symptoms in humans. Follow-up experiments showed that the compound was effective against all other coronaviruses tested, including the SARS and MERS coronaviruses. The researchers also demonstrated efficient inhibition of virus in cells that line the human airways and are the natural port of entry for respiratory viruses.

Advertisement

Examining K22's mechanism of action, they discovered that the compound acts at an early step during the production of coronavirus in human host cells. Human cells are subdivided into different "compartments", for example the nucleus that contains the genetic information, or the mitochondria, which are the cell's power plants. Each compartment is surrounded by a wall-like structure called a "membrane". In order to multiply (i.e. manufacture new virus) and spread the infection, coronaviruses need to usurp and re-shape some of the membranes in the human host cells to build a sort of scaffolding for their virus production machinery. The results here show that K22 inhibits coronaviruses by preventing this use of host membranes for viral production.

"The remarkable efficacy of K22-mediated inhibition of coronavirus replication", the authors say, "confirms that the employment of host cell membranes for viral RNA synthesis is a crucial step in the coronavirus life cycle, and importantly, demonstrates that this step is extremely vulnerable and also druggable for antiviral intervention" Because the identification of K22 and its proposed mode-of-action is only the first, preclinical, step towards a therapeutic use, they also argue that "one important lesson of the past SARS and recent MERS coronavirus outbreaks is the need to invest significant efforts to developing efficacious and approved drugs to increase preparedness and combat coronavirus infections".

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Middle East Respiratory Syndrome Coronavirus Indian Namaste the Preferred Greeting over Conventional Handshake COVID in Children COVID Vaccination for Pregnant Women COVID-19 Vaccine: Myths and Facts Mental Health during COVID-19: Top Tips to Manage COVID Anxiety, Depression How to Find Joy and Hope during COVID Times Omicron Variant of COVID-19 

Most Popular on Medindia

Hearing Loss Calculator Vent Forte (Theophylline) Drug - Food Interactions Drug Side Effects Calculator Post-Nasal Drip Turmeric Powder - Health Benefits, Uses & Side Effects Accident and Trauma Care Blood - Sugar Chart Pregnancy Confirmation Calculator How to Reduce School Bag Weight - Simple Tips
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Antiviral Activity of New Coronavirus Inhibitor Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests